Suchergebnisse - "Friberg, Lena E"

PubPharm (295)

61

Model-Informed Drug Development for Anti-Infectives : State of the Art and Future

enthalten in: Clinical pharmacology and therapeutics | 2021

von Rayner, C. | Smith, P. | Andes, D. | +12

CommentIn: Clin Pharmacol Ther. 2021 Dec;110(6):1426-1428. - PMID 34555178

62

Pivotal Role of Translation in Anti-Infective Development

enthalten in: Clinical pharmacology and therapeutics | 2021

von Friberg, L.

63

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria : relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

64

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

65

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

enthalten in: Frontiers in pharmacology | 2021

von van Eerden, R. | van Doorn, L. | de Man, F. | +12

66

Model‐Informed Drug Development for Antimicrobials : Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin

enthalten in: Clinical Pharmacology & Therapeutics | 2021

von Sou, T. | Hansen, J. | Liepinsh, E. | +13

67

Pivotal Role of Translation in Anti‐Infective Development

enthalten in: Clinical Pharmacology & Therapeutics | 2021

von Friberg, L.

68

Model‐Informed Drug Development for Anti‐Infectives : State of the Art and Future

enthalten in: Clinical Pharmacology & Therapeutics | 2021

von Rayner, C. | Smith, P. | Andes, D. | +12

69

From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics

enthalten in: Clinical Pharmacology & Therapeutics | 2021

von Wicha, S. | Märtson, A. | Nielsen, E. | +4

70

Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2021

von Krishnan, S. | Friberg, L. | Bruno, R. | +3